Home › Targets › CD22

CD22 (1 companies · 1 programs)

Companies with an active program directed at CD22.

Autolus Therapeutics plc AUTL

AUTO1/22 — Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia Phase 1